Literature DB >> 30814672

Anti-CD19 CAR T cell therapy for lymphoma - off to the races!

David G Maloney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30814672     DOI： 10.1038/s41571-019-0183-7

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  5 in total

1.  Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer.

Authors:  Ke Li; Jing Xu; Jing Wang; Chong Lu; Yilin Dai; Qing Dai; Wang Zhang; Congjian Xu; Shu Wu; Yu Kang
Journal:  Cancer Immunol Immunother       Date:  2022-09-27       Impact factor: 6.630

2.  TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL.

Authors:  Harbani K Malik-Chaudhry; Kirthana Prabhakar; Harshad S Ugamraj; Andrew A Boudreau; Benjamin Buelow; Kevin Dang; Laura M Davison; Katherine E Harris; Brett Jorgensen; Heather Ogana; Duy Pham; Ute Schellenberger; Wim Van Schooten; Roland Buelow; Suhasini Iyer; Nathan D Trinklein; Udaya S Rangaswamy
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 3.  Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Authors:  Aleksandra Kusowska; Matylda Kubacz; Marta Krawczyk; Aleksander Slusarczyk; Magdalena Winiarska; Malgorzata Bobrowicz
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

4.  Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma.

Authors:  Kaidong Liu; Yiding Geng; Linzhu Wang; Huanhuan Xu; Min Zou; Yawei Li; Zhangxiang Zhao; Tingting Chen; Fengyan Xu; Liang Sun; Shuliang Wu; Yunyan Gu
Journal:  Mol Oncol       Date:  2022-07-22       Impact factor: 7.449

Review 5.  Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Authors:  Yunzhen Qian; Yitao Gong; Zhiyao Fan; Guopei Luo; Qiuyi Huang; Shengming Deng; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  J Hematol Oncol       Date:  2020-10-02       Impact factor: 17.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.